Bank of America Sets New $15.00 Price Target for Amicus Therapeutics Following Positive Readout
☀️Trending News Amicus Therapeutics ($NASDAQ:FOLD) is a global biotechnology company dedicated to developing and delivering innovative therapies for rare and [...]
Amicus Therapeutics Intrinsic Value Calculation – American Century Companies Reduces Stock Holdings in Biopharmaceutical Company Amicus Therapeutics
🌥️Trending News Amicus Therapeutics ($NASDAQ:FOLD) is a biopharmaceutical company that is focused on developing treatments for rare and orphan diseases. [...]
Amicus Therapeutics Stock Fair Value – Leerink Partners Downgrades FY2023 EPS Estimate for Amicus Therapeutics,
🌥️Trending News Leerink Partners, a financial services firm, recently downgraded their forecasted earnings per share (EPS) estimate for Amicus Therapeutics [...]
Amicus Therapeutics Intrinsic Value Calculator – AMICUS THERAPEUTICS Reports Third Quarter Earnings for 2023 on November 8
🌥️Earnings Overview On November 8, 2023, AMICUS THERAPEUTICS ($NASDAQ:FOLD) announced its fiscal year 2023 quarterly earnings results ending on September [...]
Amicus Therapeutics Stock Fair Value Calculation – AMICUS THERAPEUTICS Announces Third Quarter FY2023 Earnings on November 8th
🌥️Earnings Overview On November 8 2023, AMICUS THERAPEUTICS ($NASDAQ:FOLD) reported their fiscal third quarter earnings for the period ending September [...]
AMICUS THERAPEUTICS Reports 17.1% Increase in Second Quarter FY2023 Revenue of USD 94.5 Million
☀️Earnings Overview AMICUS THERAPEUTICS ($NASDAQ:FOLD) reported total revenue of USD 94.5 million for the second quarter of their fiscal year [...]
AMICUS THERAPEUTICS Reports Earnings for Q2 FY2023
🌥️Earnings Overview AMICUS THERAPEUTICS ($NASDAQ:FOLD) announced their second quarter fiscal year 2023 earnings results on June 30, 2023, with a [...]
CEO Bradley L. Campbell Cashes Out 20,000 Shares of Amicus Therapeutics Stock
☀️Trending News Amicus Therapeutics ($NASDAQ:FOLD), Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines to [...]
Amicus Therapeutics’ Upcoming Earnings Call: A Moment of Opportunity Amidst Positive Momentum
☀️Introduction: Amicus Therapeutics, a leading biotechnology company specializing in rare genetic diseases, is set to announce their second-quarter earnings results [...]
Amicus Therapeutics Intrinsic Value – Cantor Fitzgerald Increases FY2023 Earnings Per Share Estimates for Amicus Therapeutics,
☀️Trending News Amicus Therapeutics ($NASDAQ:FOLD), Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of treatments for [...]
